Diagnosed with Cancer? Your two greatest challenges are understanding cancer and understanding possible side effects from chemo and radiation. Knowledge is Power!
Learn about conventional, complementary, and integrative therapies.
Dealing with treatment side effects? Learn about evidence-based therapies to alleviate your symptoms.
Click the orange button to the right to learn more.
Metformin and Cancer: Why This Diabetes Drug Is Being Studied
Metformin and Cancer: Why This Diabetes Drug Is Being Studied for Tumors- Metformin is one of the most widely prescribed medications for type 2 diabetes, used by more than 150 million people worldwide.
Over the past two decades, researchers have investigated whether metformin may also play a role in cancer prevention or therapy.
Why would a diabetes drug be relevant to cancer?
Cancer and metabolic disease share several biological pathways, including insulin signaling, inflammation, and abnormal cellular metabolism, scientists have discovered that metformin affects many of these same systems.
This does not mean metformin is a proven cancer treatment. However, it explains why this inexpensive generic medication continues to be studied in laboratory research, epidemiologic studies, and clinical trials.
I am a long-term survivor of an incurable blood cancer called multiple myeloma. My research and experience with evidence-based non-conventional therapies is the reason why I have lived in complete remission from my incurable blood cancer since achieving complete remission in early 1999. I have learned that the best way to manage aggressive cancers is to combine the best of conventional and evidence-based non-conventional therapies.
I have come to believe that therapy-induced side effects can be life-threatening while ruining quality of life. Consider therapies shown to reduce possible side effects.
Consider preparing your body for whatever treatment plan you choose with:
- intravenous vitamin C therapy
- prehabilitation
- enhancing your gut microbiome
- healing your immune system after chemo and radiation
Scroll down the page and post a question or a comment if there’s anything you’d like to know about breast cancer.
Good luck,
David Emerson
Why is metformin studied for cancer?
Metformin is studied for cancer because it may lower insulin levels, activate AMPK, inhibit the mTOR growth pathway, and alter tumor metabolism. These effects could potentially slow cancer cell growth, although clinical trial evidence remains mixed.
Can a Diabetes Drug Really Help Fight Cancer? | Metformin for Cancer
What is Metformin?
Metformin is an oral medication used to treat type 2 diabetes and insulin resistance.
It works primarily by:
- reducing glucose production in the liver
- improving insulin sensitivity
- lowering circulating insulin levels
Because high insulin and metabolic dysfunction are associated with several cancers, researchers began investigating whether metformin might influence tumor growth.
Research overview:
https://pubmed.ncbi.nlm.nih.gov/39595655/
Why Would a Diabetes Drug Matter in Cancer?
Cancer cells often depend on altered metabolic pathways to grow rapidly.
Several conditions linked to metabolic dysfunction increase cancer risk:
- obesity
- insulin resistance
- chronic inflammation
- elevated insulin and IGF-1 signaling
Metformin targets some of these same pathways, which is why researchers began exploring its potential role in oncology.
Scientific review:
https://pmc.ncbi.nlm.nih.gov/articles/PMC10998183/
How Metformin May Affect Cancer Cells
Researchers have proposed several mechanisms through which metformin might influence tumor biology.
1. Lowering Insulin Levels
High insulin levels can stimulate cancer cell growth.
Metformin reduces circulating insulin in many patients, which may decrease growth signals that tumors rely on.
Study overview:
https://pubmed.ncbi.nlm.nih.gov/40701453/
2. Activating AMPK (The Cell’s Energy Sensor)
AMPK is a key regulator of cellular energy balance.
When AMPK is activated, cells shift away from growth and toward energy conservation. Metformin is known to activate AMPK, which may suppress cancer cell proliferation.
Research:
https://pmc.ncbi.nlm.nih.gov/articles/PMC10998183/
3. Inhibiting the mTOR Growth Pathway
mTOR is a major signaling pathway that regulates cell growth and protein synthesis.
Many cancers show overactive mTOR signaling. Metformin may inhibit this pathway indirectly through AMPK activation.
Research review:
https://pmc.ncbi.nlm.nih.gov/articles/PMC9178677/
4. Altering Tumor Metabolism
Cancer cells often rely heavily on mitochondrial energy production.
Metformin appears to interfere with mitochondrial function in some cancer cells, potentially making the environment less favorable for tumor growth.
Mechanism review:
https://pmc.ncbi.nlm.nih.gov/articles/PMC10998183/
5. Influencing Inflammation and the Tumor Microenvironment
Some studies suggest metformin may influence immune signaling and inflammation within the tumor microenvironment.
However, these effects remain an active area of investigation.
Research overview:
https://pubmed.ncbi.nlm.nih.gov/40701453/
What Does Research Actually Show?
Evidence on metformin and cancer falls into three major categories.
1. Observational Studies
Several population studies have suggested that diabetic patients taking metformin may experience:
- lower cancer incidence
- improved cancer survival
Example analysis:
https://pmc.ncbi.nlm.nih.gov/articles/PMC10995851/
However, observational studies cannot prove causation.
2. Laboratory and Preclinical Research
In laboratory models, metformin has demonstrated potential anti-tumor effects including:
- reduced cancer cell proliferation
- altered tumor metabolism
- inhibition of growth signaling pathways
These findings provide the biological rationale for further research.
3. Clinical Trials
Clinical trials evaluating metformin as a cancer therapy have produced mixed results.
Some trials show modest benefits in specific settings, while others show little or no effect.
Clinical trial listings:
https://www.cancer.gov/research/participate/clinical-trials/intervention/metformin-hydrochloride
Researchers are now studying whether metformin works best:
- in combination with other therapies
- in metabolically unhealthy patients
- in specific cancer subtypes
Which Cancers Have Been Studied?
Metformin has been investigated across many cancer types, particularly those linked to metabolic disease.
These include:
- breast cancer
- colorectal cancer
- pancreatic cancer
- prostate cancer
- endometrial cancer
- ovarian cancer
- liver cancer
- glioma and other brain tumors
Scientific review:
https://pmc.ncbi.nlm.nih.gov/articles/PMC10998183/
However, the strength of evidence varies widely between cancer types.
Why Metformin Is Still Being Studied
Metformin has several characteristics that make it appealing for cancer research:
- long safety record
- inexpensive generic medication
- well-understood metabolic effects
- potential interaction with major cancer signaling pathways
However, translating laboratory results into real-world cancer therapy remains challenging.
Could Metformin Work Best in Certain Patients?
Some researchers believe metformin may be most beneficial in patients with:
- type 2 diabetes
- insulin resistance
- obesity
- metabolic syndrome
These conditions are associated with metabolic environments that may support tumor growth.
More research is needed to determine which patients, if any, benefit the most.
Safety Considerations
Metformin has a long history of use in diabetes care and is generally considered safe when prescribed appropriately.
However, it may cause side effects such as:
- gastrointestinal upset
- vitamin B12 deficiency with long-term use
- rare risk of lactic acidosis in patients with kidney dysfunction
Patients should never start metformin for cancer treatment without physician supervision.
Bottom Line
Metformin is being studied for cancer because it influences several biological pathways linked to tumor growth, including insulin signaling, cellular metabolism, AMPK activation, and mTOR inhibition.
While laboratory research and observational studies have produced encouraging signals, clinical trial results remain mixed.
For now, metformin should be viewed as a promising research topic rather than a proven anti-cancer therapy.
To Learn More About Repurposed Drugs for Cancer-
- Fenbendazole and Cancer: What the Research Really Shows”
- Mebendazole and Cancer: Anti-Tumor Mechanisms and Studies”
- Repurposed Drugs in Cancer Therapy: What the Science Shows”
- Metformin and Cancer: Why a Diabetes Drug Is Being Studied for Tumors
- Repurposed Drugs in Cancer Therapy: What the Science Shows
- Repurposed Drugs + Chemotherapy: Integrative Treatment
Metformin and Cancer: Why This Diabetes Drug Is Being Studied
Metformin and Cancer: Why This Diabetes Drug Is Being Studied
Metformin and Cancer: Why This Diabetes Drug Is Being Studied
Metformin and Cancer: Why This Diabetes Drug Is Being Studied